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Juvenile idiopathic arthritis (JIA) is not a disease, but an
exclusion diagnosis that encompasses all forms of arthritis
that begin before the age of 16 years, persist for more than
6 weeks, and are of unknown origin. This heterogeneous
group of chronic arthritides has been classified on clinical
and laboratory grounds to try to identify homogeneous,
mutually exclusives categories suitable for etiopathogenic
studies. During the last years evidence has accumulated
suggesting that while some JIA categories identify quite
definite disease entities, others represent heterogeneous
conditions and in particular that a homogeneous disease
entity (ANA positive, early onset oligoarthritis) is included
in several different JIA categories. These and other
findings suggest the need to reconsider some aspects of
the current International League of Associations for
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